key: cord-0768095-1e7phd13
authors: Lee, Lydia; Iyer, Sriram; Jose, Ricardo J.; Manuel, Ari
title: COVID-19 follow-up planning: what will we be missing?
date: 2020-05-26
journal: ERJ Open Res
DOI: 10.1183/23120541.00198-2020
sha: 5c5f2b7e4b0a1bfb8ffcdb87927eab75750c2536
doc_id: 768095
cord_uid: 1e7phd13

There is a real need for a discharge plan for COVID-19 survivors in the UK. Follow-up imaging could help assess the resolution of infection, exclude underlying malignancy and identify post-inflammatory fibrosis. https://bit.ly/2YJ8hyg

Increasing age, smoking and immunosuppression are common risk factors of pneumonia, and are thought to increase the severity of COVID-19. These are also risk factors for malignancy, and importantly, undiagnosed cancer can be a risk factor for pneumonia and potentially COVID-19 [3] . A cohort study looking at the incidence of cancer after hospital admission with CAP showed 28 496 (8.3%) out of 342 609 patients had cancer diagnosed in follow-up, suggesting that pneumonia increased the risk of all cancers but especially that of the lung [4] . Another study found 13 (1.3%) out of 1011 patients admitted with CAP had underlying lung cancer with eight being found on admission with chest radiography and the rest in convalescence [5] . Cancer cases identified in SARS follow-up are unknown.

From early stages of COVID-19 to recovery, computed tomography (CT) changes have been shown to progress from ground-glass opacity (GGO), to a crazy paving pattern, to consolidation and then gradual resolution of findings [6] . Another study of 98 confirmed COVID-19 patients from 4 to 88 years of age also found bilateral GGO present during infection that resolved after treatment [7] . It is also worth noting that lung adenocarcinomas present early on in CT with GGO, with the potential to advance into more solid components [8] .

In addition to determining resolution of infection and excluding underlying malignancy, in the current pandemic, follow-up imaging will be useful to identify those with residual pulmonary fibrosis. The development of post-inflammatory fibrosis following viral pneumonia and adult respiratory distress syndrome has been well described [9] . The incidence and course are unclear, although it appears to be more common and debilitating in survivors of severe disease [10] . It would therefore be rational to limit follow-up imaging to patients who present with severe COVID-19 disease, particularly as a CT scan may be required for confirmation.

The increasing number of cases would undoubtedly overwhelm the radiology department. Especially as the infectious period is still unknown, extra precautions would have to be implemented to protect the staff and @ERSpublications There is a real need for a discharge plan for COVID-19 survivors in the UK. Follow-up imaging could help assess the resolution of infection, exclude underlying malignancy and identify postinflammatory fibrosis. https://bit.ly/2YJ8hyg

World Health Organization. WHO hospital discharge and follow-up policy for patients who have been diagnosed with Severe Acute Respiratory Syndrome (SARS)

British Thoracic Society guidelines for the management of community acquired pneumonia in adults: update

Risk factors for community-acquired pneumonia in adults in Europe: a literature review

Pneumonia and the incidence of cancer: a Danish nationwide cohort study

Association of pneumonia and lung cancer: the value of convalescent chest radiography and follow-up

Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia

High-resolution computed tomography manifestations of COVID-19 infections in patients of different ages

Management of ground-glass opacities: should all pulmonary lesions with ground-glass opacity be surgically resected?

Post-ARDS pulmonary fibrosis in patients with H1N1 pneumonia: role of follow-up CT

Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors